Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




Biomolecule Detection Technology to Make Lab-on-a-Chip Devices Smaller, Faster

By LabMedica International staff writers
Posted on 20 Jul 2022

New research has overcome a major challenge to isolating and detecting molecules at the same time and at the same location in a microdevice. The work by scientists at the University of Massachusetts Amherst (Amherst, MA, USA) demonstrates an important advance in using graphene for electrokinetic biosample processing and analysis and could allow lab-on-a-chip devices to become smaller and achieve results faster.

“For the detection of biomolecules, we usually first have to isolate them in a complex medium in a device and then send them to another device or another spot in the same device for detection,” said Jinglei Ping, an assistant professor at the Mechanical and Industrial Engineering Department, who is also affiliated with the Institute of Applied Life Sciences. “Now we can isolate them and detect them at the same microscale spot in a microfluidic device at the same time.

“No one has ever demonstrated this before,” he continued. “This is owing to our use of graphene, a nanomaterial as thin as a single carbon atom, as microelectrodes in a microfluidic device. We found that, compared to typical inert-metal microelectrodes, the electrolysis stability for graphene microelectrodes is more than 1,000 times improved, making them ideal for high-performance electrokinetic analysis.”

Also, Ping added, since monolayer graphene is transparent, “we developed a three-dimensional multi-stream microfluidic strategy to microscopically detect the isolated molecules and calibrate the detection at the same time from a direction normal to the graphene microelectrodes.”

The new approach developed in the work paves the way to the creation of lab-on-a-chip devices of maximal time and size efficiencies, Ping said. Also, the approach is not limited to analyzing biomolecules and can potentially be used to separate, detect and stimulate microorganisms such as cells and bacteria.

Related Links:
University of Massachusetts Amherst 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
New
Gold Member
TORCH Panel Rapid Test
Rapid TORCH Panel Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get complete access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The AI predictive model identifies the most potent cancer killing immune cells for use in immunotherapies (Photo courtesy of Shutterstock)

AI Predicts Tumor-Killing Cells with High Accuracy

Cellular immunotherapy involves extracting immune cells from a patient's tumor, potentially enhancing their cancer-fighting capabilities through engineering, and then expanding and reintroducing them into the body.... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.